Lenti-hTERT-Neo Virus, High Titer
Cat. No.
LV622
Unit
2 x 100 µl
Price
$1025.00
| Cat. No. | LV622 |
| Name | Lenti-hTERT-Neo Virus, High Titer |
| Unit | 2 x 100 µl |
| Description |
High Titer Lentivirus containing hTERT with resistance to Neomycin (109 IU/ml) |
| Application |
Reliable and commonly used. May cause cell death in some cell types (eg. epithelial cells). |
| Expression System Type | Lentivirus |
| Vector Map | pLenti-hTERT-Neo |
| Note |
*For for-profit organizations and corporations, the purchase price is 1.5 times the listing price. |
| Caution |
NOT FOR RESALE without prior written consent of abm. This product is distributed for laboratory research only. Caution: Not for diagnostic use. |
| Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LV622 |
Print & Download Datasheet
There are no FAQs for this product yet!
- Jung, A et al. "Increased Alternative Lengthening of Telomere Phenotypes of Telomerase-negative Immortal Cells upon Trichostatin - A Treatment" Anticancer Res. 33 (3):821-829 (2013). Application: Immortalization.
- Balducci, L et al. "Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors" Stem Cell Research & Therapy 3:63 (2014). DOI: 10.1186/scrt452. PubMed: 24887516. Application: Immortalization.
- Olyslaegers, DA et al. "Generation and characterization of feline arterial and venous endothelial cell lines for the study of the vascular endothelium" BMC Vet. Res. 9:170 (2013). DOI: 10.1186/1746-6148-9-170. PubMed: 23987139. Application: Immortalization.
- Ohshima, S et al. "Establishment of Proliferative Tetraploid Cells from Telomerase-Immortalized Normal Human Fibroblasts" Genes, Chromosomes, and Cancer 55.6:522-530 (2016). DOI: 10.1002/gcc.22354. Application: Immortalization.
- Zhou, GL et al. "Deficits in receptor-mediated endocytosis and recycling in cells from mice bearing a disruption of the Gpr107 locus " J Cell Sci 127(18):3916-3927 (2014). DOI: 10.1242/jcs.135269. PubMed: 24849652.
- Krishna, V. D. et al. "Differential Induction of Type I and Type III Interferons by Swine and Human Origin H1N1 Influenza A Viruses in Porcine Airway Epithelial Cells" PLoS One 9:e0138704 (2015). DOI: 10.1371/journal.pone.0138704. PubMed: 26384331.
- Hsuan-Shun, H et al. "Efficient analyses of DNA double-strand breaks and the cell cycle in the secretory epithelial cells of fallopian tube fimbriae" Tzu Chi Medical Journal 3:102-106 (2015). DOI: http://dx.doi.org/10.1016/j.tcmj.2015.05.004.
- Cacchiarelli, D et al. "Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency" Cell 2:412-424 (2015). DOI: 10.1016/j.cell.2015.06.016. PubMed: 26186193.
- Huang, H. S. et al. "Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis" Carcinogenesis 11:1419-1428 (2015). DOI: 10.1093/carcin/bgv132. PubMed: 26363031.
- Nauwynck, H.J. et al. "Generation and Characterization of feline arterial and cenous endotheilial cell lines for the study of the vascular endothelium " Biomed Central 9: (2013). DOI: 10.1186/1746-6148-9-170. Application: Gene Delivery.
- Laval, et al. "Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells" Journal of Virology 21:10912-10923 (2015). DOI: 10.1128/JVI.01589-15.
- Ohshima, S et al. "Establishment of proliferative tetraploid cells from telomerase-immortalized normal human fibroblasts" Genes, Chromosomes and Cancer 6:522-530 (2016). DOI: DOI: 10.1002/gcc.22354. Application: Infection and immortalization.
- Ohshima, S et al. "Establishment of Proliferative Tetraploid Cells from Telomerase-Immortalized Normal Human Fibroblasts" Genes, Chromosomes, and Cancer 55.6:522-530 (2016). DOI: 10.1002/gcc.22354. Application: Immortalization.
- Chou, YY et al. "Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9" Sci. Rep. 6.36921: (2016). DOI: 10.1038/srep36921. Application: Immortalization.
This product has no review yet.